Notably, BRAFV600E-positive HT29 colon cancer cells also exhibited TFEB nuclear translocation upon PLX4720 treatment, suggesting a BRAFV600E-specific event (Supplementary Fig. 2d). Here, TFEB is linked to malignant colon neoplasm.